Citation: Mp. Jones et al., VARIATION IN TEST-RESULTS FOR APC RESISTANCE WITH FACTOR-V DEFICIENT PLASMA FROM DIFFERENT DONORS, Thrombosis and haemostasis, 77(3), 1997, pp. 601-601
Citation: Jt. Tesar et B. Alving, INCREASE OF SOLUBLE P-SELECTIN (SPS) AND VON-WILLEBRAND-FACTOR (VWF) LEVELS IN BLOOD OF PATIENTS WITH SLE AND ANTIPHOSPHOLIPID ANTIBODY SYNDROME (APS), Arthritis and rheumatism, 40(9), 1997, pp. 1610-1610
Citation: Mp. Jones et al., CASE-CONTROLLED, PROSPECTIVE-STUDY OF THE PREVALENCE OF FACTOR-V LEIDEN AMONG AMBULATORY PATIENTS PRESENTING WITH VENOUS THROMBOEMBOLISM, Blood, 88(10), 1996, pp. 691-691
Authors:
MCLOUGHLIN TM
FONTANA JL
ALVING B
MONGAN PD
BUNGER R
Citation: Tm. Mcloughlin et al., PROFOUND NORMOVOLEMIC HEMODILUTION - HEMOSTATIC EFFECTS IN PATIENTS AND IN A PORCINE MODEL, Anesthesia and analgesia, 83(3), 1996, pp. 459-465
Authors:
GREILICH P
ALVING B
HEALEY P
CHANG A
ONEILL K
REID T
Citation: P. Greilich et al., MONITORING THE ANTIPLATELET EFFECTS OF C7E3 FAB (REOPRO(TM)) IN HEPARINIZED SURGICAL PATIENTS, Anesthesiology, 83(3A), 1995, pp. 98-98